Nadim Ahmed
Board Member
Cullinan Therapeutics, Inc. (CGEM)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-10-18–present
-
Current
2021-01-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cullinan Therapeutics, Inc. (CGEM) | President and Chief Executive Officer | $698,476 | $5,100,006 |
| 2024 | Cullinan Therapeutics, Inc. (CGEM) | President and Chief Executive Officer | $674,856 | $7,684,366 |
| 2023 | Cullinan Therapeutics, Inc. (CGEM) | President and Chief Executive Officer | $648,900 | $4,008,206 |
| 2022 | Cullinan Therapeutics, Inc. (CGEM) | President and Chief Executive Officer | $618,000 | $3,900,527 |
| 2021 | Cullinan Therapeutics, Inc. (CGEM) | President and Chief Executive Officer | $125,000 | $38,547,200 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.